{
    "clinical_study": {
        "@rank": "138104", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die.\n\n      PURPOSE: Phase I trial to study the effectiveness of MEN-10755 in treating patients who have\n      solid tumors."
        }, 
        "brief_title": "MEN-10755 in Treating Patients With Solid Tumors", 
        "condition": [
            "Testicular Germ Cell Tumor", 
            "Unspecified Adult Solid Tumor, Protocol Specific"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms, Germ Cell and Embryonal", 
                "Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Determine the maximum tolerated dose of MEN-10755 in patients with solid\n      tumors. II. Determine the qualitative and quantitative toxic effects of this drug and study\n      the predictability, duration, intensity, onset, reversibility and dose relationship of the\n      toxic effects in this patient population. III. Propose a safe dose for phase II study. IV.\n      Study the pharmacokinetics of this drug at different dose levels in this patient population.\n      V. Document any possible antitumor activity of this drug in this patient population.\n\n      OUTLINE: This is a dose escalation study. Patients receive MEN-10755 IV over 15 minutes on\n      days 1, 8, and 15. Treatment continues every 4 weeks, or upon recovery of toxicity,\n      whichever comes later. Treatment continues for at least 2 courses in the absence of\n      unacceptable toxicity or disease progression. Cohorts of 3-6 patients receive escalating\n      doses of MEN-10755 until the maximum tolerated dose (MTD) is determined. The MTD is defined\n      as the dose preceding that at which 2 of 6 patients experience dose limiting toxicity.\n      Patients are followed for at least 3 weeks.\n\n      PROJECTED ACCRUAL: A total of 30 patients will be accrued for this study over 12 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically or cytologically confirmed solid tumor that is not\n        amenable to standard therapy Measurable or evaluable disease No brain involvement or\n        leptomeningeal disease\n\n        PATIENT CHARACTERISTICS: Age: 18 and over Performance status: WHO 0-2 Life expectancy: At\n        least 3 months Hematopoietic: Absolute neutrophil count at least 1,500/mm3 Platelet count\n        at least 100,000/mm3 Hepatic: Bilirubin no greater than 1.5 mg/dL Liver function tests no\n        greater than 2 times upper limit of normal (ULN) (no greater than 5 times ULN if liver\n        metastases present) Renal: Creatinine no greater than 1.4 mg/dL Creatinine clearance at\n        least 60 mL/min Cardiovascular: LVEF at least 50% (by MUGA) Other: Not pregnant or nursing\n        Fertile patients must use effective contraception No active infections No other\n        nonmalignant disease that precludes study No history of alcoholism, drug addiction, or\n        psychotic disorders\n\n        PRIOR CONCURRENT THERAPY: Biologic therapy: At least 4 weeks since prior immunotherapy\n        Chemotherapy: At least 4 weeks since prior chemotherapy (6 weeks for nitrosoureas,\n        mitomycin, and high dose carboplatin) No other concurrent antitumor drugs Endocrine\n        therapy: No concurrent corticosteroids Radiotherapy: At least 4 weeks since prior\n        radiotherapy (6 weeks for extensive radiotherapy) No concurrent radiotherapy Surgery: Not\n        specified Other: No prior anthracyclines or anthracenediones No other concurrent\n        investigational drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00003982", 
            "org_study_id": "EORTC-16970", 
            "secondary_id": "EORTC-16970"
        }, 
        "intervention": {
            "intervention_name": "sabarubicin", 
            "intervention_type": "Drug"
        }, 
        "keyword": [
            "unspecified adult solid tumor, protocol specific", 
            "testicular embryonal carcinoma and yolk sac tumor"
        ], 
        "lastchanged_date": "July 10, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-16970"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Innsbruck", 
                        "country": "Austria", 
                        "zip": "A-6020"
                    }, 
                    "name": "Innsbruck Universitaetsklinik"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Vienna", 
                        "country": "Austria", 
                        "zip": "A-1100"
                    }, 
                    "name": "Kaiser Franz Josef Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1000"
                    }, 
                    "name": "Institut Jules Bordet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "B-1200"
                    }, 
                    "name": "Ludwig Institute for Cancer Research-Brussels Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edegem", 
                        "country": "Belgium", 
                        "zip": "B-2650"
                    }, 
                    "name": "Universitair Ziekenhuis Antwerpen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Herlev", 
                        "country": "Denmark", 
                        "zip": "DK-2730"
                    }, 
                    "name": "Herlev Hospital - University Hospital of Copenhagen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63011"
                    }, 
                    "name": "Centre Jean Perrin"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "Centre Leon Berard"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nantes-Saint Herblain", 
                        "country": "France", 
                        "zip": "44805"
                    }, 
                    "name": "CRLCC Nantes - Atlantique"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31052"
                    }, 
                    "name": "Institut Claudius Regaud"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villejuif", 
                        "country": "France", 
                        "zip": "F-94805"
                    }, 
                    "name": "Institut Gustave Roussy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany", 
                        "zip": "D-45122"
                    }, 
                    "name": "Universitaetsklinik und Strahlenklinik - Essen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nuremberg (Nurnberg)", 
                        "country": "Germany", 
                        "zip": "D-90419"
                    }, 
                    "name": "Klinikum Nurnberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1117 MB"
                    }, 
                    "name": "Academisch Ziekenhuis der Vrije Universiteit"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands", 
                        "zip": "1066 CX"
                    }, 
                    "name": "Antoni van Leeuwenhoekhuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Groningen", 
                        "country": "Netherlands", 
                        "zip": "9713 EZ"
                    }, 
                    "name": "Academisch Ziekenhuis Groningen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nijmegen", 
                        "country": "Netherlands", 
                        "zip": "NL-6252 HB"
                    }, 
                    "name": "University Medical Center Nijmegen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oslo", 
                        "country": "Norway", 
                        "zip": "N-0310"
                    }, 
                    "name": "Norwegian Radium Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Basel", 
                        "country": "Switzerland", 
                        "zip": "CH-4031"
                    }, 
                    "name": "University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "CH-3010"
                    }, 
                    "name": "Inselspital, Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint Gallen", 
                        "country": "Switzerland", 
                        "zip": "CH-9007"
                    }, 
                    "name": "Kantonsspital - Saint Gallen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle Upon Tyne", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NE4 6BE"
                    }, 
                    "name": "Newcastle General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dundee", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "DD1 9SY"
                    }, 
                    "name": "Ninewells Hospital and Medical School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "EH4 9NQ"
                    }, 
                    "name": "Western General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G61 1BD"
                    }, 
                    "name": "C.R.C. Beatson Laboratories"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Denmark", 
                "France", 
                "Germany", 
                "Netherlands", 
                "Norway", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Phase I Study to Determine the Safety of MEN-10755 (BMS-195615) in Patients With a Solid Tumor on a Short I.V. Infusion Given Once Every Week for 3 Consecutive Weeks, Followed by One Week's Rest", 
        "overall_official": {
            "affiliation": "University Medical Centre Groningen", 
            "last_name": "Emma Geertruida Elisabeth De Vries, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00003982"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 1997", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }, 
    "geocoordinates": {
        "Academisch Ziekenhuis Groningen": "53.219 6.567", 
        "Academisch Ziekenhuis der Vrije Universiteit": "52.37 4.895", 
        "Antoni van Leeuwenhoekhuis": "52.37 4.895", 
        "C.R.C. Beatson Laboratories": "55.864 -4.252", 
        "CRLCC Nantes - Atlantique": "47.21 -1.602", 
        "Centre Jean Perrin": "45.777 3.087", 
        "Centre Leon Berard": "45.764 4.836", 
        "Herlev Hospital - University Hospital of Copenhagen": "55.73 12.425", 
        "Innsbruck Universitaetsklinik": "47.269 11.404", 
        "Inselspital, Bern": "46.948 7.445", 
        "Institut Claudius Regaud": "43.605 1.444", 
        "Institut Gustave Roussy": "48.793 2.359", 
        "Institut Jules Bordet": "50.85 4.352", 
        "Kaiser Franz Josef Hospital": "48.208 16.374", 
        "Kantonsspital - Saint Gallen": "47.424 9.371", 
        "Klinikum Nurnberg": "49.499 11.078", 
        "Ludwig Institute for Cancer Research-Brussels Branch": "50.85 4.352", 
        "Newcastle General Hospital": "54.978 -1.618", 
        "Ninewells Hospital and Medical School": "56.462 -2.971", 
        "Norwegian Radium Hospital": "59.914 10.752", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Universitaetsklinik und Strahlenklinik - Essen": "51.462 7.009", 
        "Universitair Ziekenhuis Antwerpen": "51.153 4.438", 
        "University Hospital": "47.557 7.593", 
        "University Medical Center Nijmegen": "51.843 5.855", 
        "Western General Hospital": "55.953 -3.188"
    }
}